DocDollars

Chugai Pharmaceutical Co., Ltd.

Japan · Reporting entity ID 100000010434

Total reported 2019–2025
$15.7M
#379 of 2,960 reporting companies — 0% of all reported industry payments
$2.17M in general payments across 747 records, plus $13.6M in research funding across 1,951 records.

How it breaks down

General payments $2,172,424
Research funding $13,553,403

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Chugai Pharmaceutical Co., Ltd. reported $15.7M to US doctors and teaching hospitals from 2019 to 2025, ranking #379 of 2,960 reporting companies. 86% of that was research funding and 14% general payments such as consulting, speaking, food and travel. 747 general payment records and 1,951 research records were filed.

Common questions about Chugai Pharmaceutical Co., Ltd.

How much has Chugai Pharmaceutical Co., Ltd. paid US doctors?

Chugai Pharmaceutical Co., Ltd. reported $15,725,827 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $2,172,424 in general payments, $13,553,403 in research funding.

How does Chugai Pharmaceutical Co., Ltd. rank among drug and device companies?

It ranks #379 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Chugai Pharmaceutical Co., Ltd. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.